Canon Medical Introduces New Configuration of Aquilion ONE / GENESIS Edition

A Comprehensive Cardiac CT Solution Powered by Artificial Intelligence New System Rounds Out CT Portfolio that Provides Clinicians with Innovative Cardiac Capabilities

Canon Medical notes to meet the growing cardiovascular imaging needs of healthcare systems, Canon Medical Systems USA, Inc. is introducing a new configuration of the Aquilion ONE / GENESIS Edition – the Aquilion ONE / GENESIS SP – a complete CT solution with proven cardiovascular capabilities. The Aquilion ONE / GENESIS SP was designed for the evolving needs of structural and coronary imaging, enabling consistent, high-quality studies through its AI-powered wide-area CT.

Canon Medical reports the Aquilion ONE / GENESIS SP enhances Canon Medical’s suite of Collaborative imaging tools which deliver clarity and confidence across the patient care cycle. Collaborative imaging provides a complete, integrated solution that helps medical practitioners address cardiovascular disease at every stage in the process — from evaluation to treatment, offering a wide range of features for complete cardiac care, including innovative CT technologies such as:

  • Improved diagnostic confidence across patients with one-beat, whole-heart acquisition and Advanced intelligent Clear-IQ Engine (AiCE) Deep Learning Reconstruction (DLR), which enables clinicians to obtain sharp, clear and distinct images.
  • Enhanced workflow capabilities because of automated tools from acquisition through analysis such as SURECardio and Vitrea Advanced Visualization, which can help clinicians manage their new increase in patient volume, and also deliver proven consistency in high image quality.
  • A lower total cost of ownership with a small footprint (204 square feet) that can fit into most existing CT rooms, unique scalability to fit varying technology needs and Power Save Mode improvements that enable the Aquilion ONE GENESIS / SP to require less cost to operate.
  • Patient-centric enhancements to help improve safety, comfort and access, including a wide bore (78 cm) and wide (47 cm) and low (33 cm) couch.

“Due to expanding applications of CT for structural heart procedures and coronary imaging, healthcare providers are growing their cardiac CT programs. At Canon Medical, we are committed to providing technologies that help clinicians keep pace with these evolving clinical pathways,” said Erin Angel, managing director, CT Business Unit, Canon Medical Systems USA, Inc. “Canon Medical’s CT product line, including the Aquilion ONE / GENESIS SP, is designed to offer complete cardiac capabilities. The platform was designed to be intuitive, making the acquisition of high-quality images easy and reliable across the full spectrum of patients and clinical scenarios.”

Canon Medical is showcasing the all-new Aquilion ONE / GENESIS SP and its full suite of innovative cardiac capabilities for high-quality routine cardiac imaging at this year’s virtual Society of Cardiac Computed Tomography (SCCT) annual meeting. Visit the booth here.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.